兄弟科技(002562) - 2019 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2019 was ¥311,707,146.99, a decrease of 25.52% compared to ¥418,535,032.58 in the same period last year[7] - The net profit attributable to shareholders was a loss of ¥25,424,067.35, representing a decline of 135.11% from a profit of ¥72,403,731.75 in the previous year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥33,227,742.47, down 146.60% from ¥71,298,551.27 year-on-year[7] - Basic and diluted earnings per share were both -¥0.03, a decline of 123.08% from ¥0.13 in the previous year[7] - The total comprehensive income for Q1 2019 was a loss of CNY 27,090,150.39, compared to a comprehensive income of CNY 72,047,665.01 in the same period last year[37] - The total profit for Q1 2019 was a loss of CNY 23,000,818.70, compared to a profit of CNY 88,658,785.50 in the same period last year[36] Cash Flow and Liquidity - The net cash flow from operating activities was a negative ¥42,691,727.13, a decrease of 136.19% compared to ¥117,960,913.55 in the same period last year[7] - Cash and cash equivalents decreased by 43.56% to ¥319,721,036.96 from ¥566,475,543.62, primarily due to the purchase of financial products with raised funds[15] - The cash flow from operating activities showed a decrease, with cash received from sales of goods and services at CNY 235,791,629.54, down from CNY 367,901,689.70 in the previous year[43] - The total cash and cash equivalents decreased by 246,754,506.66 CNY during the period, compared to a decrease of 64,198,850.90 CNY in the previous period[45] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,585,655,908.90, a slight increase of 0.10% from ¥3,581,986,748.10 at the end of the previous year[7] - The total liabilities increased to CNY 726,470,299.73 from CNY 679,741,830.68, indicating a rise in financial obligations[32] - The company's equity decreased to CNY 2,290,716,908.21 from CNY 2,312,760,672.35, reflecting a decline in retained earnings[33] - Total assets amounted to CNY 3,581,986,748.10, with non-current assets at CNY 2,139,075,545.46[52] Operational Costs and Expenses - Total operating costs increased to CNY 342,639,092.00, up from CNY 331,543,081.00, reflecting a rise in operating costs[34] - The gross profit margin decreased due to an increase in operating costs, which rose to CNY 86,856,225.08 from CNY 70,802,798.71, representing a year-over-year increase of approximately 22.67%[39] - Research and development expenses decreased to CNY 14,327,262.53, down from CNY 15,353,395.51, indicating a focus on cost management[34] - The company's net profit margin was impacted, with a significant increase in financial expenses to CNY 11,972,068.31 from CNY 24,529,513.93 in the previous period[34] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 34,520[11] - The company repurchased a total of 6,790,640 shares, accounting for 0.7737% of the total share capital, with a total payment of ¥29,997,182.48[16] Future Outlook - The company expects a net profit of -¥25,576,200.00 for the first half of 2019, compared to a net profit of ¥85,254,100.00 in the same period of 2018, due to significant price declines in the vitamin market[18] Other Information - The company executed a new accounting standard change, impacting the financial reporting[55] - The first quarter report was not audited, which may affect the reliability of the financial data presented[56] - The company has not disclosed any new product developments or market expansion strategies in this report[55] - There were no significant mergers or acquisitions reported during this quarter[55]